180 Life Sciences
Latest reporting and timeline
180 Life Sciences plans $2.9m stock offering during iGaming pivot
180 Life Sciences plans to raise about $2.9m through a direct stock offering as it shifts towards online gaming and gambling, according to a 30 December filing with the US Securities and Exchange Commission. The proposed sale covers 1.2 million common shares at $2.41 each, alongside warrants for another 1.2 million shares; the company expects the proceeds to support its market entry efforts.
Connections
Mentioned alongside
Named in the same reports; not a stated relationship.
Flag an issue
Get daily updates on 180 Life Sciences
New reports on 180 Life Sciences, free. At most one email a day.